Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,231,037
+$1,944,841 QoQ
Shares Held
169,657
-0.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#135
of 751 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. EXEL ranks #3 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in EXEL
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,231,037 | 169,657 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,286,196 | 169,881 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,341,938 | 144,694 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,735,451 | 163,086 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,948,111 | 134,939 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,378,675 | 118,599 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,885,244 | 116,674 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,071,286 | 118,354 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $663,179 | 29,514 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $788,144 | 33,213 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $282,794 | 11,788 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $262,221 | 12,001 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $223,625 | 11,702 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $225,214 | 11,603 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $201,510 | 12,563 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $160,124 | 10,212 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||